|
Sponsorship and Display Opportunities Available
|
 This is a one-day
conference organized annually by the Southern California Biomedical
Council (SoCalBio) to showcase the
strength and future of the bioscience industry in Los
Angeles/Orange County and surrounding
communities.
Click here for a PDF version of the
agenda
Click here for a PDF of the list of speakers
 This conference will:
-
Showcase
emerging bioscience firms and technologies looking
for capital and seeking partnerships
-
Offer
keynote presentation and panel discussions to help
entrepreneurs navigate an economy that is both
challenging and changing
-
Highlight
the role of public/private partnerships in
sustaining a regional culture of innovation and
entrepreneurship
-
Explore
new and realistic bioscience commercialization
business models given changes in the economy,
consumer behavior and public policy
-
Create
an environment for rich networking and information
exchange among various bioscience industry
stakeholders
SoCalBio Investor & Partnership Conference
Morning Keynote to be Delivered by Internationally Recognized Authority on
Global, Economic, Political and Social Trends, Joel Kotkin
Mr. Kotkin will talk about strategies to
maintain and increase California's economic and technological competitiveness in
a rapidly changing world economy.
Described by the New York Times as America’s “uber-geographer,” for over three decades Mr. Kotkin has been one of the
nation's most prolific and widely-published journalists. He is a highly respected speaker and futurist, he consults for many leading economic development organizations, private companies, regions and cities.
Most recently, he wrote "THE NEXT HUNDRED MILLION: America in 2050," a book published in February
2010 by The Penguin Press. The book explores how the nation will evolve in the next four decades. It has received rave reviews from The New York Times, Wall Street Journal, the Globe and Mail, and National Public Radio...
Click here to read more about Mr. Kotkin
SoCalBio Investor & Partnership Conference
Luncheon Keynote to be Delivered by Bioscience Industry Veteran Perry Karsen
LOS ANGELES--(BUSINESS WIRE)--The Southern California Biomedical Council (SoCalBio) is pleased to announce that Perry Karsen - chief operations officer of Celgene Corporation (NASDAQ: CELG) - will deliver the keynote address at the 12th Annual SoCalBio Investor & Partnership Conference, which will be held Thursday, November 4th at the J W Marriott of L.A. Live in downtown Los Angeles
Mr. Karsen's keynote will focus on collaboration trends during and following the current economic downturn. It will target executives at emerging medical device, biotechnology and healthcare informatics firms by building on this year's conference theme: "Sustaining Innovation in a Challenging Economy."
Most recently, Mr. Karsen served as president and CEO of Pearl Therapeutics, which develops double and triple combination therapies for highly prevalent respiratory diseases. From 2004-2009, he served as senior vice president and head of worldwide business development for Celgene Corporation (his current employer), where he was also president of the Asia/Pacific Region. Prior to joining Celgene, he was senior vice president of business development at Human Genome Sciences (NASDAQ: HGSI - News). ... Click here to read the rest of the press release
Interested in Making a
Presentation During This Conference?
 
Device, biotech and health
informatics companies interested in making business presentations during this
event should send non-confidential executive summaries to scbc@socalbio.org.
When summaries are received,
interested firms will be invited to make presentations to the company selection
committee on any of the following dates:
- June 15, 1 to 4
- June 25, 1 to 4
- July 20, 1 to 4
- August 11, 1 to 4
- August 25, 1 to 4
- September 14, 1 to 4
- September 29, 1 to 4
- October 13, 1 to 4
- October 27, 1 to 4
Selected
companies will be mentored to ensure that their presentations meet the highest
standards required by investors and potential partners.
Click
here for more info | |
|
Who
Should Attend? |
- Biotech, pharma, IVD,
informatics and
medical device company executives
- Venture capitalists
- Angel investors
- Investment bankers
- Life-science educators and
researchers
- Service providers
- Policy makers
- Economic development
professionals
- Media Representatives
|
|
What Did They
Say About Last Year's Conference? |
| "I was very impressed by the SoCalBio
Conference in many ways. First, it was a well- organized and seamless process. I enjoyed the location, the concurrent sessions and the food. More importantly, I liked the select group of professionals, and the companies lined up. It was a great experience and a helpful seminar for
me."
Varaz Shahmirian, Ph.D.
Laursar Technologies (Northridge, CA)
"It was my pleasure to participate in this year's conference. Overall, I was very pleasantly impressed with the conference. The
attendees were a good mix of bio and life-science business folks and service providers. I met lots of people who were either potential clients
or referral sources. I was surprised how many attendees I already knew-- which made the conference more enjoyable. The
sessions that I attended ran smoothly, with good audience attendance and participation."
Mark Benedict, Ph.D.
Knobbe Martens
(Irvine, CA) | |
